These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 9273301)
1. [Schizophrenia: receptors and clinical aspects]. Azorin JM Encephale; 1997 Apr; 23 Spec No 2():17-9. PubMed ID: 9273301 [TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapy of schizophrenia: a review. Sigmundson HK Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S70-5. PubMed ID: 7533053 [TBL] [Abstract][Full Text] [Related]
3. [Dopamine D2 and serotonin 5HT2 receptors: functions, interactions and clinical consequences in schizophrenia]. Guise S; Soubrouillard C; Blin O Encephale; 1997 Apr; 23 Spec No 2():10-6. PubMed ID: 9273300 [TBL] [Abstract][Full Text] [Related]
4. Conventional versus novel antipsychotics: changing concepts and clinical implications. Remington G; Chong SA J Psychiatry Neurosci; 1999 Nov; 24(5):431-41. PubMed ID: 10586534 [TBL] [Abstract][Full Text] [Related]
5. Recent concepts in clinical psychiatry: drug treatment in schizophrenia. Hussain SH J Pak Med Assoc; 1991 Sep; 41(9):229-34. PubMed ID: 1683911 [No Abstract] [Full Text] [Related]
6. New perspectives on the clinical neurobiology of treatment response in schizophrenia. Honer WG Can J Psychiatry; 1994 Feb; 39(1):34-42. PubMed ID: 7910778 [TBL] [Abstract][Full Text] [Related]
7. Neuroleptic treatment of patients with schizophrenia. Mechanisms of action and clinical significance. Wiesel FA Br J Psychiatry Suppl; 1994 Apr; (23):65-70. PubMed ID: 7913610 [TBL] [Abstract][Full Text] [Related]
8. [Methodological constraints in evaluating anti-deficit effects]. Boyer P; Lecrubier Y; Rein W Encephale; 1996 Jun; 22 Spec No 2():25-7. PubMed ID: 8767038 [TBL] [Abstract][Full Text] [Related]
9. The neurobiology of cognition in schizophrenia. Tamminga CA J Clin Psychiatry; 2006; 67 Suppl 9():9-13; discussion 36-42. PubMed ID: 16965183 [TBL] [Abstract][Full Text] [Related]
10. The neurochemical circuitry of schizophrenia. Carlsson A Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S10-4. PubMed ID: 16508890 [TBL] [Abstract][Full Text] [Related]
11. [Problems in evaluating new antipsychotic drugs]. Fleischhacker WW Wien Med Wochenschr; 1998; 148(11-12):266-72. PubMed ID: 9746969 [TBL] [Abstract][Full Text] [Related]
12. Clinical implications of PCP, NMDA and opiate receptors. Wilkins J NIDA Res Monogr; 1989; 95():275-81. PubMed ID: 2577034 [No Abstract] [Full Text] [Related]
13. [Effect of neuroleptics on depressive symptoms]. Tabeze JP Encephale; 1998 Jul; 24 Spec No 1():38-41. PubMed ID: 9809254 [No Abstract] [Full Text] [Related]
14. [Schizophrenia and neural transmission: an excess of analogical treatment?]. Tassin JP Encephale; 1996 Oct; 22 Spec No 3():91-8. PubMed ID: 9036015 [No Abstract] [Full Text] [Related]
15. [Depressive symptoms in schizophrenia]. Gerard A Encephale; 1998 Jul; 24 Spec No 1():24-6. PubMed ID: 9809250 [No Abstract] [Full Text] [Related]
16. [Psychopharmacologic approaches to schizophrenic psychoses]. Giacardy-Paty M; Soubrouillard C; Blin O Encephale; 1995 Jun; 21 Spec No 3():3-8. PubMed ID: 7628339 [TBL] [Abstract][Full Text] [Related]
17. [Deficit schizophrenias]. Puech AJ Encephale; 1996 Jun; 22 Spec No 2():1. PubMed ID: 8767033 [No Abstract] [Full Text] [Related]
18. New drugs for the treatment of schizophrenic patients. Fleischhacker WW Acta Psychiatr Scand Suppl; 1995; 388():24-30. PubMed ID: 7604735 [TBL] [Abstract][Full Text] [Related]
19. "Postpsychotic depression" and residual schizophrenia in a mental health hospital. Mauri MC; Laini V; Barone R; Clemente A; Volonteri LS; Cerveri G; Steinhilber C; Fornier M Encephale; 2000; 26(6):21-6. PubMed ID: 11217534 [TBL] [Abstract][Full Text] [Related]
20. "Awakening" from schizophrenia: intramolecular polypharmacy and the atypical antipsychotics. Stahl SM J Clin Psychiatry; 1997 Sep; 58(9):381-2. PubMed ID: 9378687 [No Abstract] [Full Text] [Related] [Next] [New Search]